Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eidos Therapeutics
Eidos Therapeutics
Watch Out, Pfizer: This $2 Billion Biotech Is Coming for You
Motley Fool
Sat, 11/23/19 - 04:11 pm
Pfizer
Vyndaqel
ATTR-CM
Eidos Therapeutics
AG10
These Biotechs Were Focused on One Line on Pfizer’s Earnings Report
Motley Fool
Thu, 10/31/19 - 11:51 pm
Pfizer
Vyndaqel
Alnylam
Akcea Therapeutics
Ionis Pharmaceuticals
Eidos Therapeutics
BridgeBio looks to fully own its CV subsidiary Eidos
BioCentury
Fri, 08/9/19 - 07:39 pm
BridgeBio
M&A
Eidos Therapeutics
Can Pfizer Leap Over the Competition With This Potential Blockbuster?
Motley Fool
Wed, 05/8/19 - 10:03 am
Pfizer
Vyndamax
tafamidis
ATTR
Alnylam
Onpattro
Akcea Therapeutics
Tegsedi
Eidos Therapeutics
AG10
Bio IPO Madness: Six Biotech Startups Raise $568M in 24 Hours
Xconomy
Thu, 06/21/18 - 12:04 pm
biotech
IPOs
Eidos Therapeutics
Avrobio
XERIS
Aptinyx
Kezar Life Sciences
Magenta Therapeutics
Eidos Therapeutics raises $106M IPO to advance ATTR med
Fierce Biotech
Wed, 06/20/18 - 03:41 pm
Eidos Therapeutics
IPOs
ATTR
rare disease
Rare Disease Biotechs Avrobio, Eidos Therapeutics File for IPOs
Xconomy
Sat, 05/26/18 - 09:22 am
Avrobio
Eidos Therapeutics
Rare Diseases
IPOs